Science Explorer Back to mapMap
Discussion
Researcher · Evotec (Germany) · Germany

Seamus P. Ragan

Seamus P. Ragan publishes mostly in Molecular Biology, Nephrology and Oncology, on topics such as Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes and CAR-T cell therapy research.

ORCID 0000-0002-0836-1236 OpenAlex
World rank
#3,180,836
of 7,710,434 ranked researchers
Rank in Germany
#158,336
of 364,343
Works
32
Citations
535
Citations per work
16.7
h-index
9
i10-index 9Top 82% in Molecular Biology
Seamus P. Ragan

What does Seamus P. Ragan research?

Seamus P. Ragan's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (6%).

Health Sciences: 13 works · 41.1% of their workMedicine: 13 works · 41.1% of their workNephrology: 6 works · 17.6% of their workOncology: 4 works · 11.8% of their workPulmonary and Respiratory Medicine: 2 works · 7.8% of their workGenetics: 1 works · 3.9% of their workEverything else: 9 works · 29.5% of their workLife Sciences: 9 works · 29.4% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 23.5% of their workMolecular Biology: 8 works · 23.5% of their workImmunology and Microbiology: 2 works · 5.9% of their workImmunology: 2 works · 5.9% of their workTHEIR WORKSeamus P. Ragan32works
Life Sciences29%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1341.1%
  2. Everything else929.5%
    1. Biochemistry, Genetics and Molecular Biology823.5%
    2. Immunology and Microbiology25.9%
  1. 1Molecular Biology24% of their works
  2. 2Nephrology18% of their works
  3. 3Oncology12% of their works
  4. 4Pulmonary and Respiratory Medicine8% of their works
  5. 5Immunology6% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Seamus P. Ragan's research?

The keywords of their largest research topics: Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Chronic Kidney Disease, Glomerular Diseases, Glomerular Filtration Rate, Nephrotic Syndrome and Metastatic.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Immunotherapy72 topics
  2. CAR T Cells41 topic
  3. Chimeric Antigen Receptor41 topic
  4. Chronic Kidney Disease41 topic
  5. Glomerular Diseases41 topic
  6. Glomerular Filtration Rate41 topic
  7. Nephrotic Syndrome41 topic
  8. Metastatic31 topic
  9. Renal Cell Carcinoma31 topic
  10. Lipid Rafts21 topic
  11. Membrane Lipids21 topic
  12. NK Cell Recognition21 topic
  13. Natural Killer Cells21 topic
  14. Protein Kinases21 topic
  15. Ras Signaling21 topic
  16. Sphingolipids21 topic
  17. Sphingosine-1-Phosphate21 topic

Where does Seamus P. Ragan work?

Seamus P. Ragan's main affiliation in the publication record is Evotec (Germany), Germany.

How many publications and citations does Seamus P. Ragan have?

OpenAlex counts 32 works and 535 citations for Seamus P. Ragan, an h-index of 9, ranking #3,180,836 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Seamus P. Ragan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.